SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-24-014240
Filing Date
2024-04-10
Accepted
2024-04-10 17:06:09
Documents
14
Period of Report
2024-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 66251
  Complete submission text file 0001493152-24-014240.txt   292761

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvgn-20240327.xsd EX-101.SCH 3815
3 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tvgn-20240327_def.xml EX-101.DEF 26691
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvgn-20240327_lab.xml EX-101.LAB 36844
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvgn-20240327_pre.xml EX-101.PRE 25315
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 6124
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

IRS No.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41002 | Film No.: 24836522
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)